Q3 2026 Haemonetics Corp Earnings Call Transcript

Feb 5, 2026 / 01:00 PM GMT

Release Date Price: €55 (-1.79%)

Transcript 10-Q8-K

Key Points

Positve

Haemonetics Corp (HAE) delivered a strong quarter, raising full-year revenue, earnings, and free cash flow guidance.
Plasma performance continues to accelerate with organic growth excluding CSL at 20% in the quarter and 22% year-to-date.
Adjusted earnings per share increased by 10% in the quarter and 11% year-to-date, highlighting the quality and durability of earnings.
The company achieved a significant margin expansion, with adjusted gross margin reaching 60.2% in the third quarter.
Haemonetics Corp (HAE) generated $74 million of free cash flow in the third quarter, representing a more than threefold increase versus the prior year period.

Negative

Interventional technology revenue declined 12% in the quarter and 8% year-to-date, primarily due to softness in esophageal cooling and OEM-related headwinds.
Vascular closure revenue declined 4% in the quarter, reflecting challenges in MVP and MVP XL and electrophysiology.
Hospital revenue was down 1% in the quarter, with softness in interventional technologies impacting overall performance.
The company anticipates a slight step up in the adjusted income tax rate in the fourth quarter, which could impact net income.
Haemonetics Corp (HAE) expects interest and tax to be a headwind in the fourth quarter, reflecting a lower tax rate in the prior year and incremental interest expense.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HAE.N - Haemonetics Corp
Q3 2026 Haemonetics Corp Earnings Call
Feb 05, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentle to the quarter 2026, he hemenetics Corporation earnings conference call.

At this time all participants are on a list and only mode.

After the speaker's presentation, there will be a question-and-answer session.

To ask a question during the session, you would rear when one on your telephone, you would then hear an automated message of fasting your hands raised to withdraw your question, please press 11 again.

Please be advised that today's conference is being recorded.

I would like now to turn the conference over to Olga.

Skayat, Vice President, investor relations and treasury.

Please go ahead.

Good morning and thank you for joining us for humanetics

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.